Rationale for anti-IL-17A treatment in bullous pemphigoid

被引：0
|
作者：
Chakievska, L. [1 ]
Holtsche, M. M. [2 ]
Hammers, C. M. [2 ]
Goletz, S. [1 ]
Zillikens, D. [2 ]
Schultze, F. S. [1 ]
Hoelscher, C. [3 ]
Schmidt, E. [1 ,2 ]
机构：
[1] Univ Lubeck, Lubeck Inst Expt Dermatol, Lubeck, Germany
[2] Univ Lubeck, Dept Dermatol, Lubeck, Germany
[3] Res Ctr Borstel, Prior Area Infect, Div Infect Immunol, Borstel, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2018年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P075 (OP01
引用
收藏
页码：E31 / E32
页数：2
相关论文
共 50 条
  • [31] Anti-interleukin-17A biologics for the long-term treatment of bullous pemphigoid: A prospective, cohort study
    Bakirtzi, K.
    Sotiriou, E.
    Papadimitriou, I.
    Vakirlis, E.
    Delli, F. S.
    Ioannides, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (06) : E749 - E751
  • [32] A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer
    S. Reppert
    I. Boross
    M. Koslowski
    Ö. Türeci
    S. Koch
    H.A. Lehr
    S. Finotto
    Nature Communications, 2
  • [33] NO REACTIVATION OF DORMANT MYCOBACTERIUM TUBERCULOSIS IN HUMAN IN VITRO GRANULOMA MODEL AFTER ANTI-IL-17A TREATMENT, IN CONTRAST TO ANTI-TNFα TREATMENT
    Kapoor, N.
    Kammuller, M.
    Kolattukudy, P. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 434 - 434
  • [34] Case Report: Coexistence of bullous pemphigoid and psoriasis: Therapeutic challenge and IL17A-targeted parallel treatment strategy
    Drenovska, Kossara
    Valeva, Elia
    Shahid, Martin
    Vassileva, Snejina
    FRONTIERS IN MEDICINE, 2023, 10
  • [35] Bullous pemphigoid treatment review
    Patton, Timothy
    Korman, Neil J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (17) : 2403 - 2411
  • [36] Biological treatment for bullous pemphigoid
    Oren-Shabtai, Meital
    Mimouni, Daniel
    Nosrati, Adi
    Atzmony, Lihi
    Kaplan, Baruch
    Barzilai, Aviv
    Baum, Sharon
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] AZATHIOPRINE IN TREATMENT OF BULLOUS PEMPHIGOID
    GREAVES, MW
    BURTON, JL
    MARKS, J
    DAWBER, RPR
    BRITISH MEDICAL JOURNAL, 1971, 1 (5741): : 144 - &
  • [38] ERYTHROMYCIN TREATMENT FOR BULLOUS PEMPHIGOID
    MENSING, H
    KRAUSSE, S
    MEDIZINISCHE KLINIK, 1990, 85 (08) : 481 - 484
  • [39] Distinct and overlapping activities of interleukin (IL)-17A and tumour necrosis factor (TNF) on the expression of proinflammatory cytokines and matrix metalloproteinases in psoriatic arthritis: rationale for anti-IL-17A/anti-TNF-α combination therapy?
    Xu, X.
    Davelaar, N.
    Otten-Mus, A-M.
    Asmawidjaja, P.
    Hazes, J.
    Baeten, D.
    Vis, M.
    Bisoendial, R.
    Lubberts, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E279 - E280
  • [40] Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab
    Patra, Ashok Kumar
    Nayak, Shreenath
    Moharana, Anandita
    Ojha, Purusottam
    Das, Sanjeet Kumar
    Akhtar, Jabed
    Giri, Bishwaranjan
    Singh, Sujay
    BIOLOGICS-TARGETS & THERAPY, 2024, 18 : 257 - 271
12345